Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

被引：0
|
作者：
A Tchirkov
J-L Couderc
B Périssel
C Goumy
A Regnier
N Uhrhammer
P Verrelle
M Berger
机构：
[1] Centre Jean Perrin,
[2] Service de Cytogénétique Médicale,undefined
[3] CHU – Faculté de Médecine,undefined
[4] UMR 384 INSERM,undefined
[5] Service de Médecine Interne,undefined
[6] CH,undefined
[7] Hématologie,undefined
[8] Faculté de Médecine,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 168
页数：1
相关论文
共 50 条
  • [1] Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript
    Tchirkov, A
    Couderc, JL
    Périssel, B
    Goumy, C
    Regnier, A
    Uhrhammer, N
    Verrelle, P
    Berger, M
    LEUKEMIA, 2006, 20 (01) : 167 - 168
  • [2] Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant
    Qin, Ya Zhen
    Jiang, Bin
    Jiang, Qian
    Zhang, Yan
    Jiang, Hao
    Li, Jin Lan
    Zhu, Hong Hu
    Li, Ling Di
    Liu, Yan Rong
    Chen, Shan Shan
    Huang, Xiao Jun
    ACTA HAEMATOLOGICA, 2008, 120 (03) : 146 - 149
  • [3] Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S242 - S243
  • [4] Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib
    Cayuela, JM
    Rousselot, P
    Nicolini, F
    Espinouse, D
    Ollagnier, C
    Bui-Thi, MH
    Chabane, K
    Raffoux, E
    Callet-Bauchu, E
    Tigaud, I
    Magaud, JP
    Hayette, S
    LEUKEMIA, 2005, 19 (12) : 2334 - 2336
  • [5] Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib
    J M Cayuela
    P Rousselot
    F Nicolini
    D Espinouse
    C Ollagnier
    M H Bui-Thi
    K Chabane
    E Raffoux
    E Callet-Bauchu
    I Tigaud
    J P Magaud
    S Hayette
    Leukemia, 2005, 19 : 2334 - 2336
  • [6] Molecular breakpoint of BCR-ABL in chronic myeloid leukemia and imatinib response
    不详
    PHARMACOGENOMICS, 2010, 11 (09) : 1202 - 1203
  • [7] Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib.
    Cayuela, JM
    Rousselot, P
    Nicolini, F
    Espinouse, D
    Ollagnier, C
    Bui-Thi, MH
    Chabane, K
    Raffoux, E
    Tigaud, I
    Magaud, JP
    Hayette, S
    BLOOD, 2005, 106 (11) : 287B - 287B
  • [8] Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia
    Lin, Han-Xin
    Sjaarda, Jenny
    Dyck, Jocob
    Stringer, Randa
    Hillis, Chris
    Harvey, Maria
    Carter, Ronald
    Ainsworth, Peter
    Leber, Brian
    Pare, Guillaume
    Sadikovic, Bekim
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) : 360 - 366
  • [9] A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia
    Branford, S
    Rudzki, Z
    Hughes, TP
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) : 635 - 637
  • [10] A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia
    V H J van der Velden
    H B Beverloo
    P G Hoogeveen
    Ch M Zwaan
    Leukemia, 2007, 21 : 833 - 835
12345